Volume 16 Supplement 1

Abstracts from the 7th International Conference on cGMP Generators, Effectors and Therapeutic Implications

Meeting abstracts

Edited by Johannes-Peter Stasch, John Burnett, Harald Schmidt, Michaela Kuhn and Franz Hofmann

Publication of this supplement has been fully funded by FEBGLA e.V. Johannes-Peter Stasch is an employee of Bayer Pharma AG, Wuppertal, Germany. He holds many patents on sGC stimulators and sGC activators. John C Burnett Jr is the chairman of the advisory board for Nile Therapeutics and is a Co-Founder and the Chief Scientific Officer for Zumbro Discovery. Mayo Clinic has licensed CD-NP to Nile Therapeutics and MANP to Zumbro Discovery. The other Supplement Editors declare that they have no competing interests.

7th International Conference on cGMP Generators, Effectors and Therapeutic Implications. Go to conference site.

Trier, Germany

19-21 June 2015

Previous Page Page 1 of 6 Next Page
  1. Meeting abstract

    cGMP and cardiac hypertrophy

    Ruwan K Perera, Hariharan Subramanian, Alexander Froese, Daniela Hübscher, Konrad R Götz and Viacheslav O Nikolaev

    BMC Pharmacology and Toxicology 2015 16(Suppl 1):A12

    Published on: 2 September 2015

Previous Page Page 1 of 6 Next Page